Advertisement

Topics

Latest "Sciences Corporation" News Stories

11:27 EST 22nd January 2019 | BioPortfolio

Here are the most relevant search results for "Sciences Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Sciences Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sciences Corporation for you to read. Along with our medical data and news we also list Sciences Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sciences Corporation Companies for you to search.

Showing "Sciences Corporation" News Articles 1–25 of 4,400+

Relevant

Roivant Sciences Raises $200 Million, Bringing its Valuation to $7 Billion

Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.


Urovant Sciences nets $130.2mm in Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. netted $130.2mm in an initial public offering of 10m...

#Cannabisstocks: ( $CVSI) CV Sciences, Inc.'s PlusCBD Oil featured on Oct. 3rd Episode of ‘The Dr. Oz Show'

October 9, 2018 (Investorideas.com Newswire) CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids


CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable (“Promissory Note”) to Wiltshire, LLC in cash, thus avoiding … Continue reading → Cet article CV Sciences, Inc. Repays Remaining Debt est apparu en premier sur Bi...

Bavarian Nordic A/S - Articles of Association

Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociationThis announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Bavarian Nordic A/S via Globenewswire

Urovant Sciences files for Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.

Alimera Sciences, Inc.: Alimera Sciences Announces Canadian Regulatory Approval for ILUVIEN(R)

ATLANTA, GA / ACCESSWIRE / November 26, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today a...

German Academies of Sciences offer recommendations for the reform of doctoral practices

(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in English, by the German National Academy of Sciences Leopoldina, acatech - National Academy of Sciences and Engineering, and the Union of the German Academies of Sciences and Humanities.

Roivant Launches New China-Based Startup Sinovant Sciences

Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.

Roivant launches new startup Sinovant Sciences in China

Global healthcare company Roivant Sciences has launched a spin-off called Sinovant Sciences in Shanghai, China to primarily develop innovative therapeutics...Read More... The post Roivant launches new startup Sinovant Sciences in China appeared first on Pharmaceutical Technology.

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

Alimera Sciences, Inc.: Alimera Sciences Appoints Rick Eiswirth as Chief Executive Officer

Co-founder Dan Myers Named Non-Executive Chairman Additional Changes to the Executive Team ATLANTA, GA / ACCESSWIRE / November 29, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader i...

Catalent to Provide Manufacturing for GB Sciences’ Proprietary Parkinson’s Disease Therapies

NewsGB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease.

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares in Vistin Pharma ASA. This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that...

#jobs #lifescience Account Executive – Products (Life Sciences)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Account Executive – Products (Life Sciences) .NJ-Bridgewater, ROLE : SENIOR LIFE SCIENCES PRODUCT SALES EXECUTIVE Cognizant’s Life Sciences division has an exciting opportunity for a Senior Account Executive … Continue reading → Cet article #jobs #lifescien...

DFG announces winners of 2019 Leibniz Prizes

(Deutsche Forschungsgemeinschaft) The latest recipients of Germany's most prestigious research prize have been announced. In Bonn today, the Joint Committee of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) selected ten researchers, four women and six men, to receive the 2019 Gottfried Wilhelm Leibniz Prize. The recipients of the prize were chosen by the selection committee ...

RWS Life Sciences welcomes new VP of Quality

RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and Process, in charge of the strategic direction and implementation of its Quality system, underlying organisational processes, and change management... The post RWS Life Sciences welcomes new VP of Quality appeared first on

In 2018, Life Sciences Industry Fell Behind on Projections for M&A Activity

In 2018 alone, mergers and acquisitions (M&A) activity among the life sciences industry totaled US$198B according to the 2019 EY M&A Firepower Report. The report continues on to state that "Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfol...

CV Sciences Inc, a cannabinoid revenue maker that stands out among pot stocks

Proactive Investors contributor Bob Byrne tells Proactive's Christine Corrado he's impressed by CV Sciences (OTCQB: CVSI), as the $289 million life sciences company has reported record sales, gross profit, and net income. Byrne says the stock is already up more than 400% on a year-to-date basis, but given the company’s incredible financial performance and its chances to be up-listed to the N...

Probably Relevant

Quotient Sciences extends formulation and manufacturing operations in UK

The program’s investment has tripled the site’s GMP capacity, added new equipment for solid oral dose manufacturing and significantly increased staffing levels. Quotient Sciences CEO Mark Egerton said: The post Quotient Sciences extends formulation and manufacturing operations in UK appeared first on Pharma Business review.

Quotient Sciences expands formulation and manufacturing operations in UK

The program’s investment has tripled the site’s GMP capacity, added new equipment for solid oral dose manufacturing and significantly increased staffing levels. Quotient Sciences CEO Mark Egerton said: The post Quotient Sciences expands formulation and manufacturing operations in UK appeared first on Pharma Business review.

EXACT Sciences' (EXAS) CEO Kevin Conroy on EXACT Sciences and Pfizer Cologuard Co-promotion Agreement - Call Transcript

STAT Plus: Gilead Sciences’ board is looking for a new CEO. Here’s a list of possible contenders

Gilead Sciences is searching for a new chief executive officer. Who are the potential candidates?

Kodiak Sciences files for IPO

Ophthalmic-focused Kodiak Sciences Inc. filed for its initial public offering on the Nasdaq.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks